Sign-On Equity Award. Subject to the approval of the Board, Executive will be granted an option to purchase 320,000 shares of common stock of the Company with an exercise price per share equal to the closing price per share of the Company’s common stock on the date of grant or the last trading day preceding the date of grant if the date of grant is not a trading day (the “Option”). Subject to Executive’s continued employment by the Company, the Option shall vest over a four-year period, with 25% of the underlying shares vesting on the first anniversary of the Start Date and 6.25% of the underlying shares vesting upon the Executive’s completion of each three full months of employment thereafter. The Option will be subject to the terms of the Company’s incentive award plan under which it is granted and the award agreement evidencing the award.
Appears in 2 contracts
Samples: Employment Agreement (Omega Therapeutics, Inc.), Employment Agreement (Omega Therapeutics, Inc.)
Sign-On Equity Award. Subject to the approval of the Board, Executive will be granted an option to purchase 320,000 purchase270,000 shares of common stock of the Company with an exercise price per share equal to the closing price per share of the Company’s common stock on the date of grant or the last trading day preceding the date of grant if the date of grant is not a trading day (the “Option”). Subject to Executive’s continued employment by the Company, the Option shall vest over a four-year period, with 25% of the underlying shares vesting on the first anniversary of the Start Date and 6.25% of the underlying shares vesting upon the Executive’s completion of each three full months of employment thereafter. The Option will be subject to the terms of the Company’s incentive award plan under which it is granted and the award agreement evidencing the award.
Appears in 1 contract
Sign-On Equity Award. Subject to the approval of the Board, Executive will be granted an option to purchase 320,000 125,000 shares of common stock of the Company with an exercise price per share equal to the closing price per share of the Company’s common stock on the date of grant or the last trading day preceding the date of grant if the date of grant is not a trading day (the “Option”). Subject to Executive’s continued employment by the Company, the Option shall vest over a four-year period, with 25% of the underlying shares vesting on the first anniversary of the Start Date and 6.25% of the underlying shares vesting upon the Executive’s completion of each three full months of employment thereafter. The Option will be subject to the terms of the Company’s incentive award plan under which it is granted and the award agreement evidencing the award.
Appears in 1 contract